Cancer, Rhabdomyosarcoma
Division
East Florida
Hospital
Aventura Hospital and Medical Center
Document Type
Review Article
Publication Date
11-13-2019
Keywords
sarcoma, cancer, RMS, childhood cancer
Disciplines
Internal Medicine | Neoplasms | Oncology
Abstract
Excerpt
Rhabdomyosarcoma (RMS) is a primitive pediatric malignant soft tissue sarcoma of skeletal muscle phenotype that originates from a primitive mesenchymal cell. Most cases are diagnosed in children under the age of 6. The etiology and risk factors remain largely unknown. Most cases of rhabdomyosarcoma are sporadic; however, the disease is associated with familial syndromes. Rhabdomyosarcoma types include embryonal rhabdomyosarcoma (approximately 60%), alveolar (approximately 20%), pleomorphic (approximately 10%), and spindle/sclerosing (approximately 10%). The survival of rhabdomyosarcoma patients has improved, especially in the last decade, mainly due to interprofessional disease management approaches.
Publisher or Conference
StatPearls
Recommended Citation
Kaseb H, Kuhn J, Babiker HM. Cancer, Rhabdomyosarcoma. [Updated 2019 Nov 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507721/